Online Impact
Statistics from Altmetric.com
ARTICLE USAGE
Cited By
Article Information
Volume 27, Issue 3, pp. 775-784
PubMed
Published By
Print ISSN
Online ISSN
History
- Received March 18, 2020
- Revision received September 3, 2020
- Accepted October 12, 2020
- Published first October 15, 2020.
Article Versions
- Previous version (October 15, 2020 - 06:27).
- Previous version (January 20, 2021 - 06:07).
- You are viewing the most recent version of this article.
Copyright & Usage
©2020 American Association for Cancer Research.
Author Information
- Pierre Montay-Gruel1,#,
- Munjal M. Acharya2,#,
- Patrik Gonçalves Jorge1,3,
- Benoît Petit1,
- Ioannis G. Petridis1,
- Philippe Fuchs1,
- Ron Leavitt1,
- Kristoffer Petersson1,3,
- Maude Gondré1,3,
- Jonathan Ollivier1,
- Raphael Moeckli3,
- François Bochud3,
- Claude Bailat3,
- Jean Bourhis1,
- Jean-François Germond3,
- Charles L. Limoli2,##, and
- Marie-Catherine Vozenin1,*,##
- 1Laboratory of Radiation Oncology/DO/Radio-Oncology/CHUV, Lausanne University Hospital and University of Lausanne, Switzerland.
- 2Department of Radiation Oncology, University of California, Irvine, California.
- 3Institute of Radiation Physics/CHUV, Lausanne University Hospital, Switzerland.
- ↵*Corresponding Author:
Marie-Catherine Vozenin, Centre Hospitalier Universitaire Vaudois, Rue du Bugnon 46, Lausanne 1011, Switzerland. Phone: 41 79556 24 37; Fax: 41 21692 59 01; E-mail: marie-catherine.vozenin{at}chuv.ch
February 2021
Volume 27, Issue 3
Volume 27, Issue 3
Hypofractionated FLASH-RT as an Effective Treatment against Glioblastoma that Reduces Neurocognitive Side Effects in Mice
Jump to section
Advertisement